Treatment of ANCA-associated vasculitides (AAV)

Abstract Treatment of AAV follows the principle of a combined remission induction and maintenance strategy and is adapted in a stage and activity-adapted fashion. So far the combination therapy of glucocorticoids and conventional immunosuppressive drugs has mainly been used to control disease. This...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Autoimmunity reviews 2013-02, Vol.12 (4), p.483-486
Hauptverfasser:	Holle, Julia U, Gross, Wolfgang L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adeno-associated virus Allergy and Immunology ANCA-associated vasculitides Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy Churg-Strauss Syndrome - drug therapy Churg–Strauss syndrome (CSS) Glucocorticoids Granulomatosis with polyangiitis (GPA, Wegener's) Granulomatosis with Polyangiitis - drug therapy Humans Immunosuppressive agents Immunosuppressive Agents - therapeutic use Microscopic polyangiitis (MPA) Microscopic Polyangiitis - drug therapy Mortality Recurrence Remission Remission Induction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!